<VariationArchive VariationID="447695" VariationName="NM_000426.4(LAMA2):c.8244+3_8244+6del" VariationType="Deletion" Accession="VCV000447695" Version="16" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-23" DateCreated="2017-12-19" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="440921" VariationID="447695">
      <GeneList>
        <Gene Symbol="LAMA2" FullName="laminin subunit alpha 2" GeneID="3908" HGNC_ID="HGNC:6482" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="128883138" stop="129516566" display_start="128883138" display_stop="129516566" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129204285" stop="129837710" display_start="129204285" display_stop="129837710" Strand="+" />
          </Location>
          <OMIM>156225</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000426.4(LAMA2):c.8244+3_8244+6del</Name>
      <CanonicalSPDI>NC_000006.12:129492483:GTAAGT:GT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="129492484" stop="129492487" display_start="129492484" display_stop="129492487" variantLength="4" positionVCF="129492483" referenceAlleleVCF="TGTAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129813629" stop="129813632" display_start="129813629" display_stop="129813632" variantLength="4" positionVCF="129813628" referenceAlleleVCF="TGTAA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000426.3" sequenceAccession="NM_000426" sequenceVersion="3" change="c.8244+3_8244+6delAAGT">
            <Expression>NM_000426.3:c.8244+3_8244+6delAAGT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.129813631_129813634del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.129813631_129813634del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.129492486_129492489del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.129492486_129492489del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008678.1" sequenceAccession="NG_008678" sequenceVersion="1" change="g.614346_614349del">
            <Expression>NG_008678.1:g.614346_614349del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000426.4" sequenceAccession="NM_000426" sequenceVersion="4" change="c.8244+3_8244+6del" MANESelect="true">
            <Expression>NM_000426.4:c.8244+3_8244+6del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079823.2" sequenceAccession="NM_001079823" sequenceVersion="2" change="c.8232+3_8232+6del">
            <Expression>NM_001079823.2:c.8232+3_8232+6del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_409" sequenceAccession="LRG_409">
            <Expression>LRG_409:g.614346_614349del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_409t1" sequenceAccession="LRG_409t1">
            <Expression>LRG_409t1:c.8244+3_8244+6del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA3994770" DB="ClinGen" />
        <XRef Type="rs" ID="746678525" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000426.4(LAMA2):c.8244+3_8244+6del AND not specified" Accession="RCV000516540" Version="2">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-10-31" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000426.4(LAMA2):c.8244+3_8244+6del AND LAMA2-related muscular dystrophy" Accession="RCV000528564" Version="12">
        <ClassifiedConditionList TraitSetID="9616">
          <ClassifiedCondition DB="MedGen" ID="C5679788">LAMA2-related muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-14" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000426.4(LAMA2):c.8244+3_8244+6del AND Merosin deficient congenital muscular dystrophy" Accession="RCV002287894" Version="5">
        <ClassifiedConditionList TraitSetID="3941">
          <ClassifiedCondition DB="MedGen" ID="C1263858">Merosin deficient congenital muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-19" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000426.4(LAMA2):c.8244+3_8244+6del AND not provided" Accession="RCV003144307" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-19" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2017-12-19" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(3); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24611677</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30055037</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30293248</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(3); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2017-12-26">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3941" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3057" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy congenital, merosin negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Merosin deficient congenital muscular dystrophy</ElementValue>
                <XRef ID="Muscular+dystrophy+congenital%2C+merosin+negative/4985" DB="Genetic Alliance" />
                <XRef ID="111503008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital merosin-deficient muscular dystrophy 1A</ElementValue>
                <XRef ID="MONDO:0011925" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDC1A</ElementValue>
                <XRef Type="MIM" ID="607855" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3843" />
                <XRef ID="3843" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420014</ID>
                <ID Source="BookShelf">NBK84550</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="258" DB="Orphanet" />
              <XRef ID="C1263858" DB="MedGen" />
              <XRef ID="MONDO:0011925" DB="MONDO" />
              <XRef Type="MIM" ID="607855" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16601" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Laminin alpha 2-related dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">LAMA2-related muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0100228" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LAMA2-RD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy type 1A (MDC1A) to milder late-onset LAMA2-MD. MDC1A is typically characterized by neonatal profound hypotonia, poor spontaneous movements, and respiratory failure. Failure to thrive, gastroesophageal reflux, aspiration, and recurrent chest infections necessitating frequent hospitalizations are common. As disease progresses, facial muscle weakness, temporomandibular joint contractures, and macroglossia may further impair feeding and can affect speech. In late-onset LAMA2-MD onset of manifestations range from early childhood to adulthood. Affected individuals may show muscle hypertrophy and develop a rigid spine syndrome with joint contractures, usually most prominent in the elbows. Progressive respiratory insufficiency, scoliosis, and cardiomyopathy can occur.</Attribute>
                <XRef ID="NBK97333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="C5679788" DB="MedGen" />
              <XRef ID="MONDO:0100228" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1197639" SubmissionDate="2017-08-17" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="NM_000426.3:c.8244+3_8244+6del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000613985" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-10-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24611677</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.3:c.8244+3_8244+6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2963629</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5040422" SubmissionDate="2022-10-07" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="SUB12132600" submittedAssembly="GRCh37" title="SUB12132600" />
        <ClinVarAccession Accession="SCV002578189" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>In-house RNA studies showed skipping of exon 58; (PS3, PM3_strong, PM2, PP3)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2">
              <Name>laminin subunit alpha 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.3:c.8244+3_8244+6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607855" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12132600</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7139454" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="46007d31a2c448d03a976d08ed40ca20b2027f06f2ab0fe4cf8fac546d7b836f|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003829206" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.3:c.8244+3_8244+6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1256989" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1588438|MedGen:CN117977" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000658780" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="8" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24611677</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Comment>This sequence change falls in intron 58 of the LAMA2 gene. It does not directly change the encoded amino acid sequence of the LAMA2 protein. It affects a nucleotide within the consensus splice site. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individual(s) with congenital muscular dystrophy (PMID: 24611677; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 447695). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.129813629_129813632del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN117977" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5003195" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000426_3_LAMA2_c_8244_3_8244_6delAAGT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557389" DateUpdated="2024-07-23" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24611677</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30055037</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30293248</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with merosin deficient or partially deficient congenital muscular dystrophy (MIM#607855) and autosomal recessive limb-girdle muscular dystrophy 23 (MIM#618138). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0212 - Non-canonical splice site variant without proven consequence on splicing (no functional evidence available). (SP) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD (v2) &lt;0.01 for a recessive condition (4 heterozygotes, 0 homozygotes). (SP) 0505 - Abnormal splicing is predicted by in silico tools and three of the affected nucleotides are highly conserved. (SP) 0708 - Another variant comparable to the one identified in this case has conflicting previous evidence for pathogenicity. A comparable variant, c.8244+2dup which is also predicted to affect c.8244+3 and the nucleotides downstream has been reported as homozygous and likely pathogenic in a patient with congenital muscular dystrophy (CMD) type 1A (PMID: 30055037). However it has also been reported as a variant of uncertain significance in ClinVar. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported in 3 patients with CMD (PMIDs: 24611677, 30293248, 30055037). It has also been reported as a variant of uncertain significance in ClinVar without sufficient supporting information. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1001 - This variant has strong functional evidence supporting abnormal protein function. Immunohistochemistry study showing laminin-a2 deficiency has been reported in a CMD patient who had 2 LAMA2 variants including this variant, the phasing of those variants were undetermined but were likely in trans (PMID: 30055037). (SP) 1209 - This variant has been shown to be both maternally and paternally inherited (biallelic) (Invitae). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6655</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.3:c.8244+3_8244+6delAAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100228" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7676773" SubmissionDate="2023-10-27" DateLastUpdated="2023-11-04" DateCreated="2023-11-04">
        <ClinVarSubmissionID localKey="NM_000426.3:c.8244+3_8244+6delAAGT|MedGen:CN117977" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004099597" DateUpdated="2023-11-04" DateCreated="2023-11-04" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30055037</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30293248</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24611677</ID>
          </Citation>
          <Comment>Variant summary: LAMA2 c.8244+3_8244+6delAAGT alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.6e-05 in 250188 control chromosomes. c.8244+3_8244+6delAAGT has been reported in the literature in individuals affected with Laminin Alpha 2-Related Dystrophy (Oliveira_2018, Nair_2018, Xiong_2015). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30293248, 30055037, 24611677). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified as VUs (n=1) and pathogenic/likely pathogenic (n=3). Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.3:c.8244+3_8244+6delAAGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN117977" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13932418</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7842312" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000426.4:c.8244+3_8244+6del|OMIM:607855" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004190485" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000426.4:c.8244+3_8244+6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607855" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7139454" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7842312" TraitType="Disease" MappingType="XRef" MappingValue="607855" MappingRef="OMIM">
        <MedGen CUI="C1263858" Name="Merosin deficient congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1197639" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1256989" TraitType="Disease" MappingType="XRef" MappingValue="CN117977" MappingRef="MedGen">
        <MedGen CUI="C5679788" Name="LAMA2-related muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7676773" TraitType="Disease" MappingType="XRef" MappingValue="CN117977" MappingRef="MedGen">
        <MedGen CUI="C5679788" Name="LAMA2-related muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5040422" TraitType="Disease" MappingType="XRef" MappingValue="607855" MappingRef="OMIM">
        <MedGen CUI="C1263858" Name="Merosin deficient congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5003195" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100228" MappingRef="MONDO">
        <MedGen CUI="C5679788" Name="LAMA2-related muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

